Bicocca Open Archive

Logo unimib boa
SQUILLACE, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.454
AS - Asia 3.310
EU - Europa 2.650
SA - Sud America 640
AF - Africa 98
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.139
SG - Singapore 1.182
IT - Italia 620
CN - Cina 606
HK - Hong Kong 479
BR - Brasile 470
RU - Federazione Russa 443
VN - Vietnam 441
DE - Germania 423
SE - Svezia 307
IE - Irlanda 256
CA - Canada 253
GB - Regno Unito 143
ID - Indonesia 125
IN - India 106
FR - Francia 92
BD - Bangladesh 76
UA - Ucraina 74
AR - Argentina 69
FI - Finlandia 59
IQ - Iraq 44
DK - Danimarca 42
MX - Messico 38
NL - Olanda 36
PL - Polonia 36
ZA - Sudafrica 35
KR - Corea 34
TR - Turchia 34
AT - Austria 31
JP - Giappone 30
PK - Pakistan 27
EC - Ecuador 24
CO - Colombia 19
BE - Belgio 16
PH - Filippine 15
SA - Arabia Saudita 15
UZ - Uzbekistan 15
ES - Italia 14
CL - Cile 13
PY - Paraguay 13
VE - Venezuela 13
CH - Svizzera 12
MA - Marocco 12
KE - Kenya 11
PE - Perù 11
MY - Malesia 10
CR - Costa Rica 8
LT - Lituania 8
EG - Egitto 7
TH - Thailandia 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
BG - Bulgaria 6
DZ - Algeria 5
ET - Etiopia 5
JO - Giordania 5
KZ - Kazakistan 5
OM - Oman 5
SN - Senegal 5
AU - Australia 4
CZ - Repubblica Ceca 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
NG - Nigeria 4
NP - Nepal 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
BY - Bielorussia 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
KH - Cambogia 2
LU - Lussemburgo 2
LY - Libia 2
MM - Myanmar 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SR - Suriname 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BT - Bhutan 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 12.150
Salva come PNG Salva come JPEG
Città #
Ann Arbor 926
Singapore 719
Hong Kong 470
Ashburn 456
San Jose 345
Frankfurt am Main 303
Fairfield 281
New York 273
Dublin 246
Chandler 240
Wilmington 198
Toronto 179
Houston 145
Woodbridge 142
Ho Chi Minh City 125
Los Angeles 123
Santa Clara 119
Milan 113
Seattle 106
Jakarta 105
Chicago 104
Beijing 94
Princeton 91
Hanoi 85
Dallas 84
The Dalles 77
Cambridge 75
Hefei 68
Dearborn 56
Council Bluffs 55
Jacksonville 53
Lauterbourg 49
São Paulo 46
Dong Ket 41
Lawrence 41
Shanghai 41
Altamura 38
Rome 38
Moscow 37
Buffalo 36
London 35
Seoul 33
Helsinki 32
Guangzhou 30
Nanjing 29
Nuremberg 29
Boardman 28
Tokyo 28
San Diego 26
Johannesburg 24
Ottawa 24
Rio de Janeiro 23
Brooklyn 22
Warsaw 22
Da Nang 18
Fremont 18
Vienna 18
Amsterdam 16
Boston 16
Montreal 16
Denver 15
Phoenix 15
Andover 14
Baghdad 14
Brussels 14
Chennai 14
Munich 14
Orem 14
Tashkent 14
Bologna 13
Falls Church 13
Poplar 13
Biên Hòa 12
Changsha 11
Dhaka 11
Guayaquil 11
Hải Dương 11
Lappeenranta 11
Monza 11
Pune 11
Stockholm 11
Atlanta 10
Curitiba 10
Palermo 10
Salt Lake City 10
Belo Horizonte 9
Bogotá 9
Can Tho 9
Lachine 9
Manchester 9
Nairobi 9
Nanchang 9
Columbus 8
Edmonton 8
Elk Grove Village 8
Haiphong 8
Hangzhou 8
Lahore 8
Lima 8
Naples 8
Totale 7.744
Salva come PNG Salva come JPEG
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 350
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 348
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 339
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 319
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 317
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 311
Brachial and central blood pressure in HIV-infected subjects 310
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 302
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 294
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 291
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 284
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 273
A multidisciplinary approach to screen the post-COVID-19 conditions 266
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 253
Weight gain: A possible side effect of all antiretrovirals 251
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 249
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 246
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 246
Unmasking tuberculosis in the era of antiretroviral treatment 245
Arterial structure and function in AIDS patients: the impact of renal damage. 244
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 238
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 238
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances 227
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 221
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 207
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 202
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 201
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 201
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 199
Fattori associati con il ricovero ospedaliero per COVID-19 in 80 pazienti HIV-positivi italiani. Factors associated with hospital admission for COVID-19 in 80 Italian HIV patients. 197
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 193
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? 193
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 190
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 187
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 183
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 182
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 180
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 180
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 179
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 173
Factors Associated With Weight Gain in People Treated With Dolutegravir 173
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 170
Factors associated with hospital admission for COVID-19 in HIV patients 168
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 159
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 159
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 156
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 155
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 151
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 150
Incident diabetes in course of antiretroviral therapy 150
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens 148
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? 147
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 146
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 137
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 134
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 132
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 128
HIV and SARS-CoV-2 Co-Infection: What are the Risks? 127
Reversibility of Central Nervous System Adverse Events in Course of Art 126
Totale 12.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 0 0 132
2021/2022692 75 63 82 61 19 48 18 34 18 60 68 146
2022/20231.272 135 346 108 104 67 193 23 103 84 21 50 38
2023/20241.037 51 18 69 29 119 315 165 48 83 27 7 106
2024/20252.021 92 219 107 116 175 135 109 57 193 341 174 303
2025/20265.006 576 451 373 581 571 257 701 229 409 400 338 120
Totale 12.525